Pfizer Plans R&D, Manufacturing Expansion In Asia
This article was originally published in PharmAsia News
Executive Summary
In another indication of big pharma's expanding interest in Asia, Pfizer announced Nov. 30 that it will seek to increase the amount of R&D and manufacturing it does in that part of the world